FDA launches new digital health adcomm to tackle incoming complexities
(This story is from our new Health Tech newsletter. If you’d like to sign-up, just click here.)
The FDA on Wednesday launched a new advisory committee to review what will likely be an influx of new issues surrounding novel health tech that’s growing increasingly complex.
Like other FDA adcomms, the new Digital Health Advisory Committee will focus its attention on these complex scientific and technical issues. In this case, those issues will be related to digital health technologies, which have historically ranged from unregulated mobile health apps to highly regulated software that can help with clinical decision-making.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.